KR100861428B1 - 암 치료용 지방산 유사체 - Google Patents

암 치료용 지방산 유사체 Download PDF

Info

Publication number
KR100861428B1
KR100861428B1 KR1020037000477A KR20037000477A KR100861428B1 KR 100861428 B1 KR100861428 B1 KR 100861428B1 KR 1020037000477 A KR1020037000477 A KR 1020037000477A KR 20037000477 A KR20037000477 A KR 20037000477A KR 100861428 B1 KR100861428 B1 KR 100861428B1
Authority
KR
South Korea
Prior art keywords
alkyl
fatty acid
cells
tumor
tta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020037000477A
Other languages
English (en)
Korean (ko)
Other versions
KR20030016399A (ko
Inventor
베르게롤프
Original Assignee
티아 메디카 에이에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 티아 메디카 에이에스 filed Critical 티아 메디카 에이에스
Publication of KR20030016399A publication Critical patent/KR20030016399A/ko
Application granted granted Critical
Publication of KR100861428B1 publication Critical patent/KR100861428B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020037000477A 2000-07-13 2001-07-13 암 치료용 지방산 유사체 Expired - Fee Related KR100861428B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20003591 2000-07-13
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
PCT/NO2001/000301 WO2002003983A1 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020087014318A Division KR20080071598A (ko) 2000-07-13 2001-07-13 암 치료용 지방산 유사체

Publications (2)

Publication Number Publication Date
KR20030016399A KR20030016399A (ko) 2003-02-26
KR100861428B1 true KR100861428B1 (ko) 2008-10-02

Family

ID=19911376

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020037000477A Expired - Fee Related KR100861428B1 (ko) 2000-07-13 2001-07-13 암 치료용 지방산 유사체
KR1020087014318A Withdrawn KR20080071598A (ko) 2000-07-13 2001-07-13 암 치료용 지방산 유사체

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020087014318A Withdrawn KR20080071598A (ko) 2000-07-13 2001-07-13 암 치료용 지방산 유사체

Country Status (17)

Country Link
US (1) US7378443B2 (https=)
EP (1) EP1313463B1 (https=)
JP (1) JP2004502732A (https=)
KR (2) KR100861428B1 (https=)
CN (1) CN100569228C (https=)
AT (1) ATE320802T1 (https=)
AU (2) AU2001272860B2 (https=)
BR (1) BR0112399A (https=)
CA (1) CA2414480A1 (https=)
DE (1) DE60118198T2 (https=)
ES (1) ES2261441T3 (https=)
MX (1) MXPA02012944A (https=)
NO (2) NO20003591L (https=)
NZ (1) NZ523316A (https=)
RU (1) RU2283105C2 (https=)
WO (1) WO2002003983A1 (https=)
ZA (1) ZA200210028B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
WO2004000854A1 (en) 2002-06-20 2003-12-31 Ic Vec Limited Sulfur-containing phospholipid derivatives
NZ553260A (en) 2004-07-19 2010-12-24 Thia Medica As Composition comprising protein material and non-oxidizable fatty acid entities
NO20053519L (no) * 2005-07-18 2007-01-19 Thia Medica As Anvendelse av forbindelser som omfatter fettsyrer
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
AU2009293019A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care Inc. Solute concentration measurement device and related methods
EP3284494A1 (en) 2009-07-30 2018-02-21 Tandem Diabetes Care, Inc. Portable infusion pump system
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids
CA2904898C (en) 2013-03-11 2019-10-15 Jan Remmereit Lipid compositions containing bioactive fatty acids
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
DE102014116958B9 (de) * 2014-11-19 2017-10-05 Trumpf Laser- Und Systemtechnik Gmbh Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung
JP2018519278A (ja) * 2015-06-11 2018-07-19 ユニバーシティー オブ マイアミＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍｉａｍｉ 癌の治療及び診断
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
CN107235880B (zh) * 2017-06-30 2018-10-30 江南大学 一种含硒阳离子表面活性剂及其应用
GB201910644D0 (en) * 2019-07-25 2019-09-11 Coegin Pharma As Cancer Treatment
AU2020405068A1 (en) 2019-12-18 2022-07-07 Stinginn Llc Substituted 1,2, 4-triazoles and methods of use
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
CN115260964A (zh) * 2022-08-29 2022-11-01 烟台市福山义昌精细化工厂 一种石油油管丝扣专用密封胶及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007009700A (ja) * 2005-06-28 2007-01-18 Daikyoo Nishikawa Kk 多気筒エンジンの吸気装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686377B2 (ja) * 1985-09-30 1994-11-02 日清製粉株式会社 がん転移抑制剤
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
JPH0797320A (ja) * 1993-08-04 1995-04-11 Takuma Sasaki 制癌剤
US6358915B1 (en) * 1995-03-07 2002-03-19 George Washington University Methods for inhibiting metastasis
ES2180751T3 (es) * 1995-04-10 2003-02-16 Taiho Pharmaceutical Co Ltd Inhibidor de metastasis de cancer.
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
EP1410799B1 (en) * 1996-12-11 2010-03-31 Dana-Farber Cancer Institute, Inc. Methods and pharmaceutical compositions for inhibiting tumour cell growth
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007009700A (ja) * 2005-06-28 2007-01-18 Daikyoo Nishikawa Kk 多気筒エンジンの吸気装置

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1997003663*

Also Published As

Publication number Publication date
MXPA02012944A (es) 2004-05-17
CN1441671A (zh) 2003-09-10
AU2001272860B2 (en) 2005-11-24
KR20080071598A (ko) 2008-08-04
NO20003591D0 (no) 2000-07-13
NO20025930D0 (no) 2002-12-11
ZA200210028B (en) 2004-01-26
CN100569228C (zh) 2009-12-16
EP1313463B1 (en) 2006-03-22
WO2002003983A1 (en) 2002-01-17
AU7286001A (en) 2002-01-21
BR0112399A (pt) 2003-05-27
NO20003591L (no) 2002-01-14
EP1313463A1 (en) 2003-05-28
NO324634B1 (no) 2007-11-26
NZ523316A (en) 2004-09-24
CA2414480A1 (en) 2002-01-17
JP2004502732A (ja) 2004-01-29
KR20030016399A (ko) 2003-02-26
HK1057473A1 (zh) 2004-04-08
US7378443B2 (en) 2008-05-27
NO20025930L (no) 2003-01-13
US20040024063A1 (en) 2004-02-05
ATE320802T1 (de) 2006-04-15
DE60118198D1 (de) 2006-05-11
RU2283105C2 (ru) 2006-09-10
DE60118198T2 (de) 2007-01-25
ES2261441T3 (es) 2006-11-16

Similar Documents

Publication Publication Date Title
KR100861428B1 (ko) 암 치료용 지방산 유사체
US6284786B1 (en) Treatment of cancer using lipoic acid in combination with ascorbic acid
AU2001272860A1 (en) Fatty acid analogues for the treatment of cancer
US5004735A (en) Pharmaceutical compositions for the inhibition of tumor metastasis
KR20100137570A (ko) 약제-내성 종양에서 화학요법제 활성을 증강시키는 ｏｎ01910.ｎａ
KR20050040907A (ko) 항종양 활성 증강용 화학요법제의 조합
Bleday et al. Inhibition of rat colon tumor isograft growth with dequalinium chloride
KR19980703698A (ko) 암 전이 억제 항암제 물질
CN111281869A (zh) 褪黑素在制备用于治疗和辅助治疗骨肉瘤的药物中的应用
EP2717869A2 (en) Methods of treatment using a bcat1 inhibitor
JP6489517B2 (ja) ガン幹細胞に対する分化促進薬及び脳腫瘍治療薬
US10441564B2 (en) Fructose analogs and their combinations as anti-cancer agents
JPH10511677A (ja) イノシトール三燐酸の薬剤調製への使用
CN114177169A (zh) 一种使用硫化氢缓释供体adt-oh抑制黑色素瘤转移的方法及其应用
US5525626A (en) Treating susceptible human malignant tumors with 7-hydroxy-1,2-benzopyrone
HK1057473B (en) Fatty acid analogues for the treatment of cancer
CN102440987A (zh) 含有芹菜素及芹菜素类衍生物和青蒿素及青蒿素类衍生物的药物组合物及其应用
CN107412736A (zh) 一种抗肿瘤联合用药物及其在制备抗癌药物中的用途
US20040048807A1 (en) Angiogenesis inhibitors
CN105832727B (zh) 带有一氧化氮供体的芳香酸衍生物在制备治疗恶性肿瘤迁移疾病药物中的应用
CN120078770A (zh) 珊瑚菜素在制备药物中的应用

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20120809

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20130827

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20140926

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20140926